Intestinal fibrosis attenuates the prophylactic effect of anti-tumour necrosis factor therapy on the postoperative recurrence of Crohn’s disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

111

Figures (1-3)

Tables (1-3)

Sum=247

Publishing Process of This Article

Item

Count

Browse

Download

167

Sum=259

Aug 27, 2025 (publication date) through Aug 31, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Surg. Aug 27, 2025; 17(8): 106455
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.106455

Full Size Figure Download Figure

Figure 1 Flowchart of the patients included in this study. CD: Crohn’s disease; ICR: Ileocecal resection; IFX: Infliximab.

Citation: Ding ZY, Wang YJ, Yao DH, Tian T, Huang YH, Li YS. Intestinal fibrosis attenuates the prophylactic effect of anti-tumour necrosis factor therapy on the postoperative recurrence of Crohn’s disease. World J Gastrointest Surg 2025; 17(8): 106455
URL: https://www.wjgnet.com/1948-9366/full/v17/i8/106455.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i8.106455